The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Radiation-induced cell cycle arrest compromised by p21 deficiency
Abstract
The protein p21 is a dual inhibitor of cyclin-dependent kinases and proliferating-cell nuclear antigen (PCNA), both of which are required for passage through the cell cycle. The p21 gene is under the transcriptional control of p53 (ref. 5), suggesting that p21 might promote p53-dependent cell cycle arrest or apoptosis. p21 has also been implicated in cell senescence and in cell-cycle withdrawal upon terminal differentiation. Here we investigate the role of p21 in these processes using chimaeric mice composed partly of p21-/- and partly of p21+/+ cells. Immunohistochemical studies of the p21+/+ and p21-/- components of adult small intestine indicated that deletion of p21 has no detectable effect on the migration-associated differentiation of the four principal intestinal epithelial cell lineages or on p53-dependent apoptosis following irradiation. However, p21-/- mouse embryo fibroblasts are impaired in their ability to undergo G1 arrest following DNA damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [147]
In the citing paper
“Surprisingly, developmental senescence is not required for embryogenesis because embryos lacking p21 show minimal or no developmental defects [56].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [56]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Self-citationAltering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Self-citationMansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Self-citationDulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Flagged first, then by citations
Research works printed but not linked: 3
- Merritt, A. J. et al. Cancer Res. 54, 614–617 (1994).
- Clarke, A. R., Gledhill, S., Hooper, M. L., Bird, C. C. & Wyllie, A. H. Oncogene 9, 1767–1773 (1994).
- Li, Y.-J., Laurent-Puig, P., Salmon, R. J., Thomas, G. & Hamelin, R. Oncogene 10, 599–601 (1994).
Cited by
Sorted by citations
Items 501–600 of 1,000
Li, B., & Lee, M. Y. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101167200 · Cited by 65
Identification of Tcf-4 as a transcriptional target of p53 signalling
Rother, K., Johne, C., Spiesbach, K., Haugwitz, U., Tschöp, K., Wasner, M., Klein‐Hitpaß, L., Möröy, T., Mössner, J., & Engeland, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207464 · Cited by 65
“…target for p53-dependent transcriptional activation is the cyclin-dependent kinase inhibitor p21WAF1/CIP1 (el-Deiry et al., 1993). p53 is thought to exert its function in G1 checkpoint control mainly through increased expression from the p21 gene (Brugarolas et al., 1995; Deng et al., 1995).”
BackgroundCell-cycle regulation in immunity, tolerance and autoimmunity
Balomenos, D., & Martínez‐A, C. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01748-5 · Cited by 64
Kramer, J. L., Baltathakis, I., Alcantara, O., & Boldt, D. H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03498.x · Cited by 64
“Paradoxically, it has been noted that peripheral blood counts in p21–/– mice are normal (Brugarolas et al, 1995; Deng et al, 1995; Cheng et al, 2000).”
BackgroundJirawatnotai, S., Moons, D. S., Stocco, C. O., Franks, R. R., Hales, D. B., Gibori, G., & Kiyokawa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301206200 · Cited by 64
Endogenous Retrovirus Activation as a Key Mechanism of Anti-Tumor Immune Response in Radiotherapy
Lee, A. K., Pan, D., Bao, X., Hu, M., Li, F., & Li, C. (2020) · Radiation Research · doi:10.1667/rade-20-00013 · Cited by 69
Inhibition of Nuclear Pore Complex Formation Selectively Induces Cancer Cell Death
Sakuma, S., Raı́ces, M., Borlido, J., Guglielmi, V., Zhu, E. Y. S., & D’Angelo, M. A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0581 · Cited by 60
“Both treatments resulted in strong downregulation of NUP160 expression levels, decreased NPC numbers and increased p21 (CDKN1A) expression, a marker of G1/S cell cycle arrest (26,27) (Supplementary Fig 3A and B).”
BackgroundActivin and TGFβ use diverging mitogenic signaling in advanced colon cancer
Bauer, J. I., Özden, Ö., Akagi, N., Carroll, T. P., Principe, D. R., Staudacher, J. J., Spehlmann, M. E., Eckmann, L., Grippo, P. J., & Jung, B. H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0456-4 · Cited by 63
“Earlier studies support the view that p21 suppresses tumors by promoting cell cycle arrest in response to various stimuli [44, 45].”
BackgroundInvited Review: Effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest
Douglas, R. M., & Haddad, G. G. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01029.2002 · Cited by 65
AMF1 (GPS2) Modulates p53 Transactivation
Peng, Y., Kuo, F., Breiding, D. E., Wang, Y., Mansur, C. P., & Androphy, E. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5913-5924.2001 · Cited by 62
“activity appears to be dispensable for apoptosis (2, 9).”
BackgroundResultLiu, Y., Bohn, S. A., & Sherley, J. L. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.1.15 · Cited by 63
“Studies with cells from mice with a germline disruption of the waf1 gene indicate that the growth suppression function of the waf1 protein is limited to conditions of DNA damage (Brugarolas et al., 1995; Deng et al., 1995).”
BackgroundAnalysis of Cyclin D3-cdk4 Complexes in Fibroblasts Expressing and Lacking p27 kip1 and p21 cip1
Bagui, T. K., Jackson, R. J., Agrawal, D., & Pledger, W. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8748-8757.2000 · Cited by 63
“Two mouse models were used to test this premise: one in which the entire coding regions of p27 and p21 were eliminated (termed p27/p21) and the other in which the entire coding region of p21 and the N-terminal cyclin-cdk binding domain of p27 (termed p27N/p21) were deleted (4, 18, 24).”
MethodInfluentialAiello, F., Carullo, G., Giordano, F., Spina, E., Nigro, A., Garofalo, A., Tassini, S., Costantino, G., Vincetti, P., Bruno, A., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700145 · Cited by 62
Kanda, H., Ishii, K., Ogura, Y., Imamura, T., Kanai, M., Arima, K., & Sugimura, Y. (2007) · International Journal of Cancer · doi:10.1002/ijc.23095 · Cited by 62
Induction of genetic instability by gain-of-function p53 cancer mutants
Xu, Y. (2008) · Oncogene · doi:10.1038/sj.onc.1211023 · Cited by 63
“…transcriptional activity of p53 is critical for its functions. p21 and 14–3–3s, both transcriptional targets of p53, are required for mediating p53-dependent cell cycle G1/S and G2/M cell cycle checkpoints (el-Deiry et al., 1993; Brugarolas et al., 1995; Deng et al., 1995; Hermeking et al., 1997).”
BackgroundHubert, A., Paris, S., Piret, J., Ninane, N., Raes, M. J., & Michiels, C. (2006) · Journal of Cell Science · doi:10.1242/jcs.03069 · Cited by 65
“The cyclindependent kinase inhibitor, p21waf-1, appears to be the major effector of p53-mediated cell-cycle arrest (Brugarolas et al., 1995; Waldman et al., 1995) whereas the transcriptional induction of Bax largely contributes to p53-mediated cell death (Miyashita et al., 1994).”
Guo, H., Liu, Z., Xu, B., Hu, H., Wei, Z., Liu, Q., Zhang, X., Ding, X., Wang, Y., Zhao, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12138 · Cited by 63
“, 2007), only a few p53 target genes, namely p21, PAI-1, PML, and E2F7, are known to mechanistically contribute to cellular senescence (Brugarolas et al., 1995; Brown et al., 1997; Kagawa et al., 1999; Wang et al., 1999; de Stanchina et al., 2004; Kortlever et al., 2006; Aksoy et al., 2012; Carvajal et al., 2012).”
BackgroundInfluentialGiono, L. E., & Manfredi, J. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01967-06 · Cited by 62
“Moreover, p21 has been shown to be both sufficient and required for proper G1 arrest (5, 12, 38, 47) through binding and inhibition of cdk complexes (6, 18).”
BackgroundIdogawa, M., Sasaki, Y., Suzuki, H., Mita, H., Imai, K., Shinomura, Y., & Tokino, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2396 · Cited by 62
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
Lhuillier, C., Vanpouille‐Box, C., Galluzzi, L., Formenti, S. C., & Demaria, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.007 · Cited by 63
“Moreover, even though the molecular pathways linking RT-driven DNA damage to cellular senescence or RCD have been extensively characterized in preclinical models [49, 50] and at least in part confirmed in the clinical, the actual predictive value of other components of the DDR machinery for cancer patients remains unk…”
BackgroundDifferential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss, D. J., Lee, R. J., Troyer, D. A., Pestell, R. G., & Windle, J. J. (2002) · PubMed · Cited by 62
A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
Wang, M., & Attardi, L. D. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-025840 · Cited by 61
Willenbring, H., Sharma, A. D., Vogel, A., Lee, A. Y., Rothfuß, A., Wang, Z., Finegold, M. J., & Grompe, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.004 · Cited by 61
“, 1993) and B6;129S2-Cdkn1a/J (Brugarolas et al., 1995) (The Jackson Laboratory) mice were crossed to generate Fah / ,p21 breeders from which all Fah / and Fah / ,p21 / animals used in these studies were derived.”
Mueller, S., Cadenas, E., & Schönthal, A. H. (2000) · PubMed · Cited by 61
Nawrocki, S. T., Carew, J. S., Douglas, L., Cleveland, J. L., Humphreys, R. C., & Houghton, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0812 · Cited by 61
“A hallmark of HDAC inhibitor treatment is a dramatic up-regulation of the CDK inhibitor p21(23), which is also a transcription target induced by the tumor suppressor p53 ( 24 ).”
BackgroundChen, L., Li, J., Fan, Y., Qiu, J., Cao, L., Laurent, R., Mignani, S. M., Caminade, A., Majoral, J., & Shi, X. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00458 · Cited by 61
APE1/Ref-1 regulates PTEN expression mediated by Egr-1
Fantini, D., Fantini, D., Vascotto, C., Deganuto, M., Bivi, N., Gustincich, S., Marcon, G., Quadrifoglio, F., Damante, G., Bhakat, K. K., et al. (2008) · Free Radical Research · doi:10.1080/10715760701765616 · Cited by 58
“proapoptotic functions through p53-mediated activation [8,40,41] of p21, leading to cell cycle arrest by inhibiting cyclin-dependent kinase [44] and cyclin G [45].”
BackgroundDietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., & Engeland, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03093-4 · Cited by 59
Cytokine-Stimulated T Lymphocyte Proliferation Is Regulated by p27Kip1 1
Zhang, S., Lawless, V. A., & Kaplan, M. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6270 · Cited by 60
CHOP-dependent Regulation of p21/waf1 During ER Stress
Mihailidou, C., Papazian, I., Papavassiliou, A. G., & Kiaris, H. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000315096 · Cited by 59
High Dub3 Expression in Mouse ESCs Couples the G1/S Checkpoint to Pluripotency
van der Laan, S., Tsanov, N., Crozet, C., & Maiorano, D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.003 · Cited by 59
5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene
Osaki, M., Tatebe, S., Goto, A., Hayashi, H., Oshimura, M., & Ito, H. (1997) · APOPTOSIS · doi:10.1023/a:1026476801463 · Cited by 59
“mouse cells without p21/waf1 genes have been shown to undergo apoptosis following γ-irradiation, implying that apoptosis does not require the p21/waf1 gene.(28)”
Lü, Y., Qu, H., Qi, D., Xu, W., Liu, S., Jin, X., Song, P., Guo, Y., Jia, Y., Wang, X., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1120-x · Cited by 58
“p21 coordinates cellular senescence by inducing cell cycle arrest [41].”
Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts
Kim, B. C., Shon, B. S., Ryoo, Y. W., Kim, S. P., & Lee, K. (2001) · Journal of Dermatological Science · doi:10.1016/s0923-1811(01)00088-3 · Cited by 59
“These results are in concordance with previous studies [21,22] that irradiation of normal human skin fibroblast cultures resulted in activation of p53 via post-translational stabilization, and this led to increased expression of p21 gene, which encodes an inhibitor of cyclin-dependent kinases that are required for G1/…”
ResultP21(Cip1/WAF1) expression in the mouse testis before and after X irradiation
Beumer, T. L., Roepers‐Gajadien, H. L., Gademan, I. S., Rutgers, D. H., & de Rooij, D. G. (1997) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199707)47:3 · Cited by 59
Regenerative Response in Ischemic Brain Restricted by p21cip1/waf1
Qiu, J., Takagi, Y., Harada, J., Rodrigues, N. P., Moskowitz, M. A., Scadden, D. T., & Cheng, T. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031385 · Cited by 59
“We obtained heterozygous 129/SV p21 / mice (15) from the laboratory of Tyler Jacks (Massachusetts Institute of Technology, Cambridge, MA) and homozygous 129/SV p53 / or 129/SV p53 / mice from Jackson Laboratory under the permission of the Subcommittee on Research Animal Care of the Massachusetts General Hospital.”
MethodVaziri, H., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203016 · Cited by 59
“In the absence of p53, pRb or p21WAF1, the cell cycle arrest pathway induced by DNA damage is lost (Kastan et al., 1992; Brugarolas et al., 1995; Deng et al., 1995; Harrington et al., 1998).”
BackgroundThe promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
Salomoni, P., Bernardi, R., Bergmann, S., Changou, A., Tuttle, S. L., & Pandolfi, P. P. (2004) · Blood · doi:10.1182/blood-2004-09-3782 · Cited by 59
A Switch in p53 Dynamics Marks Cells That Escape from DSB-Induced Cell Cycle Arrest
Tsabar, M., Mock, C. S., Venkatachalam, V., Reyes, J. S., Karhohs, K. W., Oliver, T. G., Regev, A., Jambhekar, A., & Lahav, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107995 · Cited by 54
“The p53 target gene critical for mediating cell cycle arrest is CDKN1A, which encodes the cyclin-dependent kinase inhibitor p21 (Brugarolas et al., 1995; el-Deiry et al., 1993; Harper et al., 1993).”
Fernández-Arias, C., Ballesteros‐Tato, A., García, M. I., Martín‐Caballero, J., Flores, J. M., Martínez‐A, C., & Balomenos, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2296 · Cited by 59
“Although p21 deletion was predicted to lead to tumor development, it did not lead to spontaneous cancer in young mice (2, 3).”
BackgroundCarstens, M. J., Krempler, A., Triplett, A. A., van Lohuizen, M., & Wagner, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400408200 · Cited by 58
Paradigms of Growth Control: Relation to Cdk Activation
Olashaw, N., & Pledger, W. J. (2002) · Science Signaling · doi:10.1126/stke.2002.134.re7 · Cited by 59
Lu, X., Magrane, G., Yin, C., Louis, D. N., Gray, J. W., & Dyke, T. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.6017-6030.2001 · Cited by 55
“For example, p53 regulates a G1 checkpoint in fibroblasts in response to DNA damage, a response that requires transcriptional activation of the p53 target gene p21 (7, 14).”
Backgroundp53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 59
“Mouse embryonic fibroblasts lacking p21Waf1/Cip1 fail to undergo p53-dependent G1 arrest after DNA damage [55].”
BackgroundInfluentialTargeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, T., & Dai, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180009 · Cited by 58
CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo
Marshall, C. B., Krofft, R. D., Pippin, J. W., & Shankland, S. J. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00216.2009 · Cited by 57
“BALB/c mice, a strain carrying the recessive ADR susceptibility gene (67, 68), were backcrossed against c57B6 p21 / mice (4) to yield a 12th generation BALB/c p21 / strain.”
MethodNag, D., Bhanja, P., Riha, R., Sánchez-Guerrero, G., Kimler, B. F., Tsue, T. T., Lominska, C. E., & Saha, S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2751 · Cited by 59
Molecular control of cell density-mediated exit to quiescence
Fan, Y., & Meyer, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109436 · Cited by 54
“Nevertheless, unlike p21, whose deletion has only small effects on mouse development (Brugarolas et al., 1995; Deng et al., 1995), p27 deletion in mice results in increased cell proliferation, multiorgan hyperplasia, and larger body size (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al.,…”
BackgroundMdm2: A Regulator of Cell Growth and Death
Alarcon-Vargas, D., Takahashi, S., & Ronai, Z. A. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)01001-7 · Cited by 57
p21CIP1 Is Dispensable for the G2 Arrest Caused by Genistein in Human Melanoma Cells
Casagrande, F., & Darbon, J.-M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4914 · Cited by 57
Moons, D. S., Jirawatnotai, S., Tsutsui, T., Franks, R. R., Parlow, A. F., Hales, D. B., Gibori, G., Fazleabas, A. T., & Kiyokawa, H. (2002) · Endocrinology · doi:10.1210/endo.143.2.8611 · Cited by 57
“lishing G1 arrest in response to DNA damage (10, 11).”
BackgroundHuman RAD9 checkpoint control/proapoptotic protein can activate transcription of p21
Yin, Y., Zhu, A., Jin, Y. J., Liu, Y., Zhang, X., Hopkins, K. M., & Lieberman, H. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403130101 · Cited by 56
Fukushima, T., Zapata, J. M., Singha, N. C., Thomas, M., Kress, C. L., Krajewska, M., Krajewski, S., Ronai, Z. A., Reed, J. C., & Matsuzawa, S. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.002 · Cited by 56
Age-Specific Functional Epigenetic Changes in p21 and p16 in Injury-Activated Satellite Cells
Li, J., Han, S., Cousin, W., & Conboy, I. M. (2014) · Stem Cells · doi:10.1002/stem.1908 · Cited by 56
Lee, L. R., Teng, P.-N., Nguyen, H., Hood, B. L., Kavandi, L., Wang, G., Turbov, J. M., Thaete, L. G., Hamilton, C. A., Maxwell, G. L., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0493 · Cited by 56
“The Cip/Kip family plays a critical role in the cellular response to DNA damage for cell-cycle arrest (44, 45) and is upregulated in response to antiproliferative signals for cell-cycle arrest (46, 47).”
BackgroundJo, H. J., Song, J., Kim, K., Cho, Y. H., Kim, K., & Park, Y. (2008) · Oncology Reports · doi:10.3892/or.19.1.275 · Cited by 56
p21Cip1 nullizygosity increases tumor metastasis in irradiated mice.
Jackson, R. J., Engelman, R. W., Coppola, D., Cantor, A. B., Wharton, W., & Pledger, W. J. (2003) · PubMed · Cited by 56
p21: structure and functions associated with cyclin-CDK binding
Ball, K. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_10 · Cited by 56
Tanaka, Y., & Takahashi, A. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa109 · Cited by 57
RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
Sun, X., Hu, Y., Wu, J., Shi, L., Zhu, L., Xi, P.-W., Wei, J., & Ding, Q. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0968-z · Cited by 55
Cdk2-dependent Inhibition of p21 Stability via a C-terminal Cyclin-binding Motif
Zhu, H., Nie, L., & Maki, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407352200 · Cited by 55
Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors
Malumbres, M., Ortega, S., & Barbacid, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.105 · Cited by 56
“A null allele of p21Cip1 was generated in embryonic stem (ES) cells by replacing the p21Cip1 coding sequence with a neomycin-resistance cassette (Brugarolas et al., 1995; Deng et al., 1995).”
BackgroundMethodFunctional Analysis of a p21 Mutant (Arg94→ Trp) Identified in a Human Breast Carcinoma
Balbı́n, M., Hannon, G. J., Pendás, A. M., Ferrando, A. A., Vizoso, F. J., Fueyo, A., & López-Otı́n, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15782 · Cited by 55
“In fact, and according to recent data (Deng et al., 1995; Brugarolas et al., 1995), mice lacking p21, despite being defective in G1 checkpoint control, have not developed spontaneous malignancies during the first 7 months of observation, suggesting that p53-dependent suppression of early tumor…”
BackgroundSelf-citationEffect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells
Fotedar, R., Brickner, H., Saadatmandi, N., Rousselle, T., Diederich, L., Munshi, A., Jung, B. H., Reed, J. C., & Fotedar, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202693 · Cited by 55
“Our result that p21 expression leads to hypersensitivity to radiation induced death is in contrast to previous work showing that radiation induced p53 dependent apoptosis is una ected in p21 null mice (Brugarolas et al., 1995; Deng et al., 1995).”
BackgroundResultInfluentialRas versus cyclin-dependent kinase inhibitors
Lloyd, A. C. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80060-9 · Cited by 55
Kuniyasu, H., Yasui, W., Kitahara, K., Naka, K., Yokozaki, H., Akama, Y., Hamamoto, T., Tahara, H., & Tahara, E. (1997) · PubMed · Cited by 55
The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
Chari, N. S., Pinaire, N. L., Thorpe, L., Medeiros, L. J., Routbort, M. J., & McDonnell, T. J. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0327-9 · Cited by 54
“Importantly, it has been demonstrated that miR-34 can induce G1 cell cycle arrest in the absence of p21 providing a potential molecular basis for p53-dependent G1 arrest in p21-null MEFs [91, 109].”
BackgroundLi, J., Wang, Y., Sun, Y., & Lawrence, T. S. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0322:wttigp]2.0.co;2 · Cited by 54
MECHANISMS OF CELL-CYCLE CHECKPOINTS: AT THE CROSSROADS OF CARCINOGENESIS AND DRUG DISCOVERY*
Flatt, P. M., & Pietenpol, J. A. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102335 · Cited by 54
Lluis Fajas, A., Paul, C., Zugasti, O., Cam, L. L., Polanowska, J., Fabbrizio, E., Medema, R. H., Vignais, M., & Sardet, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130198397 · Cited by 54
Núñez, F., Chipchase, M. D., Clarke, A. R., & Melton, D. W. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1073 · Cited by 56
“cannot arrest in G1 after DNA damage (17, 18), and human p21-deficient cells show similar characteristics”
BackgroundCyclin A Is a Mediator of p120 E4F -Dependent Cell Cycle Arrest in G 1
Lluis Fajas, A., Paul, C., Vié, A., Estrach, S., Medema, R. H., Blanchard, J. M., Sardet, C., & Vignais, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2956-2966.2001 · Cited by 54
“p212/2 mouse embryonic fibroblasts (MEFs) (gift from T. Jacks) ( 3 ), p532/2 MEFs (gift from L. Donehower) (8), pRB2/2 MEFs (gift from D. Cobrinik), WT MEFs, NIH 3T3 cells, CCL39”
Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M. W., Mössner, J., & Engeland, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5040 · Cited by 53
Delebinski, C. I., Twardziok, M., Kleinsimon, S., Hoff, F., Mulsow, K., Rolff, J., Jäger, S., Eggert, A., & Seifert, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133892 · Cited by 53
“P21 and p27 are cyclin-dependent kinase inhibitors both of which function as regulators of cell cycle progression in a p53-dependent or independent way [78]; [79, 80].”
BackgroundHyka‐Nouspikel, N., Desmarais, J. A., Gokhale, P. J., Jones, M., Meuth, M., Andrews, P. W., & Nouspikel, T. P. (2012) · Stem Cells · doi:10.1002/stem.1177 · Cited by 52
Ghosh (2010) · International Journal of Oncology · doi:10.3892/ijo_00000627 · Cited by 52
Hu, H., Dong, Z., Tan, P., Zhang, Y., Liu, L., Yang, L., Liu, Y., & Cui, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6419 · Cited by 52
“To affirm the results, we measured the expression of CDK2 and Cyclin E which could promote cells to go through the G1/S checkpoint by Western blot.”
BackgroundResultInfluentialCellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 53
CDC2 is down-regulated by ionizing radiation in a p53-dependent manner.
Azzam, E. I., Toledo, S. D., Pykett, M. J., Nagasawa, H. T., & Little, J. B. (1997) · PubMed · Cited by 53
Haapajärvi, T., Kivinen, L., Heiskanen, A., Bordes, C. D., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4403 · Cited by 53
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients
Bordoni, V., Tartaglia, E., Sacchi, A., Fimia, G. M., Cimini, E., Casetti, R., Notari, S., Grassi, G., Marchioni, L., Bibas, M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.019 · Cited by 54
“Furthermore, a significant higher level of p21, an essential mediator of p53-dependent cell-cycle arrest (Brugarolas et al., 1995), was observed in COVID-19 patients than in HD (Figure 1D).”
Sun, Y., Xiao, L., Wang, D., Ji, Y., Yang, Y., Ma, R., & Chen, X. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3850 · Cited by 52
Gotoh, Y., Noda, T., Iwakiri, R., Fujimoto, K., Rhoads, C. A., & Aw, T. Y. (2002) · Cell Proliferation · doi:10.1046/j.1365-2184.2002.00241.x · Cited by 52
G1 versus G2 cell cycle arrest after adriamycin‐induced damage in mouse Swiss3T3 cells
Siu, W. Y., Yam, C. H., & Poon, R. Y. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01481-7 · Cited by 52
Zezula, J., Sexl, V., Hutter, C., Karel, A., Schütz, W., & Freissmuth, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29967 · Cited by 52
Viale, G., Pellegrini, C., Mazzarol, G., Maisonneuve, P., Silverman, M. L., & Bòsari, S. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199902)187:3 · Cited by 52
Hartmann, B. L., Geley, S., Loeffler, M. W., Hattmannstorfer, R., Strasser-Wozak, E. M., Auer, B., & Kofler, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202339 · Cited by 52
“G1 growth arrest has been shown to be unrelated to, or even protect from, apoptosis in most systems of p53-mediated apoptosis (Brugarolas et al., 1995; Deng et al., 1995; Gorospe et al., 1997).”
BackgroundReinke, V., & Lozano, G. (1997) · Radiation Research · doi:10.2307/3579567 · Cited by 52
On the TRAIL from p53 to apoptosis?
Kastan, M. B. (1997) · Nature Genetics · doi:10.1038/ng1097-130 · Cited by 52
Recent advances on cyclins, CDKs and CDK inhibitors
Martı́n-Castellanos, C., & Moreno, S. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(96)10055-6 · Cited by 52
Biguanides drugs: Past success stories and promising future for drug discovery
Grytsai, O., Myrgorodska, I., Rocchi, S., Ronco, C., & Benhida, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113726 · Cited by 51
Krutmann, J., & Humbert, P. G. (2010) · Springer eBooks · doi:10.1007/978-3-642-12264-4 · Cited by 82
Tan, X., Popanda, O., Ambrosone, C. B., Kropp, S., Helmbold, I., von Fournier, D., Haase, W., Sautter-Bihl, M. L., Wenz, F. K., Schmezer, P., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9119-2 · Cited by 51
“p21, together with p53, is directly involved in G1/S checkpoint control in response to IR [5].”
BackgroundParamio, J. M., Segrelles, C., Ruiz, S., Martín‐Caballero, J., Page, A., Martínez, J. L., Serrano, M., & Jorcano, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105650200 · Cited by 51
Apoptosis and the cell cycle: the p53 connection
Choisy, C., & Yonish-Rouach, E. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400339 · Cited by 51
“Mice lacking p21 were shown to be defective in the G1 checkpoint control (Brugarolas et al, 1995; Deng et al, 1995).”
BackgroundΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint
Garner, A. P., Weston, C. R., Todd, D. E., Balmanno, K., & Cook, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206000 · Cited by 50
“…et al., 1995; Deng et al., 1995; Waldmann et al., 1995) is critical for both imposing and maintaining the DNA damage-induced G1 checkpoint (Brugarolas et al., 1995; Deng et al., 1995). p21CIP1 over-expression results in inhibition of cyclin-dependent kinase 2 (CDK2)-containing complexes…”
BackgroundMomand, J. A., & Zambetti, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970301)64:3 · Cited by 167
Adachi, M., Roussel, M. F., Havenith, K., & Sherr, C. J. (1997) · Blood · doi:10.1182/blood.v90.1.126 · Cited by 51
p53-Oriented cancer therapies: Current progress
Gallagher, W. M., & Brown, R. E. (1999) · Annals of Oncology · doi:10.1023/a:1008368500557 · Cited by 51
Matsuura, K., Balmukhanov, T. S., Tauchi, H., Weemaes, C. M. R., Smeets, D. F. C. M., Chrzańowska, K., Endou, S., Matsuura, S., & Komatsu, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7924 · Cited by 51
Metadata
- Authors
- Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Washington University in St. Louis (US)
- Venue
- Nature
- Published
- 1995-10
- Volume
- 377
- Issue
- 6549
- Pages
- 552-557
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969385456
- Cited by
- 1,242
- References
- 24
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 13 · 2023: 29 · 2022: 21 · 2021: 29 · 2020: 22 · 2019: 27 · 2018: 28 · 2017: 31 · 2016: 24 · 2015: 26 · 2014: 26 · 2013: 29 · 2012: 41
- FWCI
- 33.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p21, cell cycle arrest, radiation-induced DNA damage, G1 cell cycle arrest, cyclin-dependent kinases, PCNA, p53, apoptosis, chimeric mice, intestinal epithelial differentiation, mouse embryonic fibroblasts, cellular senescence
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Cell Division, Cell Line, Cells, Cultured, Chimera, Enzyme Inhibitors, Gamma Rays, Intestine, Small, Mice, Inbred C57BL, Tumor Suppressor Protein p53, Cyclins, Apoptosis, Protein Serine-Threonine Kinases, Gene Targeting, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review